Straumann Holding AG PE Ratio 2009-2017 | SAUHF

Current and historical p/e ratio for Straumann Holding AG (SAUHF) from 2009 to 2017. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Straumann Holding AG PE ratio as of March 31, 2020 is 0.00.
Straumann Holding AG PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
0.00 nan
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $11.784B $1.130B
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $62.307B 19.76
McKesson (MCK) United States $23.932B 9.39
AmerisourceBergen (ABC) United States $18.221B 12.22
Cooper (COO) United States $14.702B 22.67
Cardinal Health (CAH) United States $13.988B 8.73
Align Technology (ALGN) United States $13.699B 35.07
Laboratory Of America Holdings (LH) United States $12.298B 11.18
West Pharmaceutical Services (WST) United States $11.243B 46.99
DENTSPLY SIRONA (XRAY) United States $8.598B 15.85
Henry Schein (HSIC) United States $7.244B 14.39
SmileDirectClub (SDC) United States $1.795B 0.00
Merit Medical Systems (MMSI) United States $1.726B 21.26
CONMED (CNMD) United States $1.632B 21.61
Patterson (PDCO) United States $1.465B 10.19
STAAR Surgical (STAA) United States $1.451B 67.21
Atrion (ATRI) United States $1.206B 32.94
Antares Pharma (ATRS) United States $0.391B 0.00
Invacare (IVC) United States $0.252B 0.00
Lifevantage (LFVN) United States $0.147B 12.41
Pro-Dex (PDEX) United States $0.063B 16.88
Milestone Scientific (MLSS) United States $0.061B 0.00
Retractable Technologies (RVP) United States $0.051B 19.50
Endologix (ELGX) United States $0.013B 0.00
Biolase (BIOL) United States $0.012B 0.00